ResMed Inc
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of ResMed Inc (RMD). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Sleep and Breathing Health | – | – | – | $3.73B 88.2% | $4.10B 87.5% · +10.1% | $4.50B 87.5% · +9.8% |
| Residential Care Software | – | – | – | $498.0M 11.8% | $584.1M 12.5% · +17.3% | $641.4M 12.5% · +9.8% |
| Total Sleep and Respiratory Care | $2.60B 88.0% | $2.82B 88.3% · +8.5% | – | – | – | – |
| Software as a Service | $354.6M 12.0% | – | – | – | – | – |
| Software as a Service | – | $373.6M 11.7% | $400.8M 11.2% · +7.3% | – | – | – |
| Sleep and Respiratory Care | – | – | $3.18B 88.8% | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Sleep and Breathing Health | – | – | – | – | – | – |
| Residential Care Software | – | – | – | – | – | – |
| Total Sleep and Respiratory Care | $934.7M 35.9% | – | – | – | – | – |
| Software as a Service | $82.2M 23.2% | – | – | – | – | – |
| Software as a Service | – | – | – | – | – | – |
| Sleep and Respiratory Care | – | – | – | – | – | – |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Revenue by region
| Segment | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $2.72B 64.4% | $2.98B 63.6% · +9.6% | $3.29B 63.8% · +10.3% |
| Rest of the World | $1.50B 35.6% | $1.71B 36.4% · +13.5% | $1.86B 36.2% · +9.1% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by product line
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Sleep and Breathing Health | – | – | – | $3.73B 88.2% | $4.10B 87.5% · +10.1% | $4.50B 87.5% · +9.8% |
| Residential Care Software | – | – | – | $498.0M 11.8% | $584.1M 12.5% · +17.3% | $641.4M 12.5% · +9.8% |
| Sleep and Respiratory Care products | $2.60B 88.0% | $2.82B 88.3% · +8.5% | $3.18B 88.8% · +12.5% | – | – | – |
| Software as a Service | $354.6M 12.0% | – | – | – | – | – |
| Software as a Service | – | $373.6M 11.7% | $400.8M 11.2% · +7.3% | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.